| Serial Number | 98212704 |
| Word Mark | TARGET GPS |
| Filing Date | Friday, October 6, 2023 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Tuesday, September 3, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Development of pharmaceutical preparations and medicines |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, October 14, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Superluminal Medicines, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02116 |
| Event Date | Event Description |
| Tuesday, October 10, 2023 | NEW APPLICATION ENTERED |
| Tuesday, May 28, 2024 | ASSIGNED TO EXAMINER |
| Monday, June 3, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, June 3, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, June 3, 2024 | NON-FINAL ACTION E-MAILED |
| Saturday, October 14, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 3, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, September 3, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, September 3, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |